BackCardiovascular Systems Overview

Cardiovascular Systems Total Current Liabilities

Cardiovascular Systems's total current liabilities is $37M.

Get informed when a big investor buys or sells

+ Follow
Total Current Liabilities
$36.76M
12.22% YoYΔ $-5.12M vs prior year quarter

Peer average

Loading

Cardiovascular Systems Total Current Liabilities History

Loading

Cardiovascular Systems vs. peers: Total Current Liabilities Comparison

Loading

Cardiovascular Systems Total Current Liabilities Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Cardiovascular Systems (CSII) FAQ

The latest total current liabilities for CSII is $37M as of December 2022. That compares with $42M in the prior-year period — down 12.2% year over year. Investors often review this figure alongside Cardiovascular Systems's historical trend and sector peers before judging valuation or financial health.

Over the past year, CSII's total current liabilities moved from $42M to $37M — a 12.2% year-over-year decrease. If the trend continues in the same direction for several quarters, it can signal a meaningful shift in Cardiovascular Systems's operating scale or balance-sheet position.

A total current liabilities figure of $37M for CSII is a snapshot of scale on that line item. On its own it does not say whether the business is healthy — you also want growth rate, margins, and how the number compares with similar companies. Explore the charts below for those layers of context.

After noting CSII's total current liabilities ($37M), review year-over-year change from $42M, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.

This page's peer comparison chart is the fastest way to stack Cardiovascular Systems's total current liabilities against similar Healthcare names. You can also browse sector and industry screens on Stockcircle for a broader set of Healthcare companies and their key multiples and fundamentals.